Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival.
Essential Thrombocythemia
Polycythemia Vera
Journal
Mediterranean journal of hematology and infectious diseases
ISSN: 2035-3006
Titre abrégé: Mediterr J Hematol Infect Dis
Pays: Italy
ID NLM: 101530512
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
09
2019
accepted:
16
12
2019
entrez:
15
1
2020
pubmed:
15
1
2020
medline:
15
1
2020
Statut:
epublish
Résumé
Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.
Identifiants
pubmed: 31934318
doi: 10.4084/MJHID.2020.008
pii: mjhid-12-1-e2020008
pmc: PMC6951352
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e2020008Déclaration de conflit d'intérêts
Competing interests: The authors declare no conflict of Interest.
Références
Blood. 2014 Oct 16;124(16):2507-13; quiz 2615
pubmed: 25037629
Ann Hematol. 2019 Jan;98(1):93-100
pubmed: 30155552
Am J Hematol. 2019 Jan;94(1):133-143
pubmed: 30281843
Leukemia. 2018 May;32(5):1057-1069
pubmed: 29515238
Blood. 2012 Dec 20;120(26):5128-33; quiz 5252
pubmed: 23033268
Am J Hematol. 2016 Mar;91(3):318-21
pubmed: 26748894
Am J Hematol. 2016 Jun;91(4):390-4
pubmed: 26799697
Blood. 2013 Sep 26;122(13):2176-84
pubmed: 23823316
Intern Emerg Med. 2010 Jun;5(3):177-84
pubmed: 19789961
Blood Rev. 2005 Sep;19(5):243-52
pubmed: 15963833
Blood Cancer J. 2017 Dec 27;7(12):662
pubmed: 29282357
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
J Clin Oncol. 2005 Apr 1;23(10):2224-32
pubmed: 15710945